NOVO — August 2024
-
Spændende interaktiv graf over samtlige obesity kandidater og deres vægttab. Fedt overblik, men har dog ikke tjekke data. https://www.baybridgebio.com/blog/obesity-clinical-data.html
-
Eli Lilly's Top GLP-1 Drugs Now Account for Nearly 40% of Its Revenue, and That's Likely to Go Higher in Future Quarters https://proinvestor.com/investornyt/1201706/eli-lillys-top-glp-1-drugs-now-account-for-nearly-40-of-its-revenue-and-thats-likely-to-go-higher-in-future-quarters
-
These 3 Healthcare Companies Had the Top-Selling Drugs Last Year https://proinvestor.com/investornyt/1201821/these-3-healthcare-companies-had-the-top-selling-drugs-last-year
-
Godmorgen
-
JKY hvor ser du den flash nyhed?
-
Godmorgen
-
Novo-bestyrelsesmedlem køber ADR'er for knap 1,4 mio. kr. https://proinvestor.com/investornyt/1203039/novo-bestyrelsesmedlem-kober-adrer-for-knap-14-mio-kr
-
Novo Nordisks amerikanske rival Eli Lilly præsenterede tirsdag positive kliniske data, der viser, at selskabets storsælgende diabetes- og fedmemiddel kraftigt reducerer risikoen for, at prædiabetikere udvikler diabetes type 2. Resultaterne er samtidig bedre i sammenligning med Novo Nordisks konkurrerende middel. Det vurderer Evan David Seigerman, analytiker i finanshuset BMO Capital Markets, ifølge Dow Jones Newswires, ifølge Børsen.
-
Lilly's tirzepatide nearly wipes out diabetes risk in overweight adults https://firstwordpharma.com/story/5887288
-
Novo-rival vil teste supersællert mod svær overvægt i psoriasispatienter https://proinvestor.com/investornyt/1203044/novo-rival-vil-teste-supersaellert-mod-svaer-overvaegt-i-psoriasispatienter
-
Til dem der måtte være interesseret, så har jeg skrevet lidt mere om Nanexa og den mulige kommende licensaftale med Novo https://proinvestor.com/boards/121761
-
Der venter en stor positiv Gubra nyhed forude. Gubra har opnået positive fase 1a data med GUBamy. Eller det er i hvert fald min konklusion ud fra en protokol opdatering. Læs mere her https://proinvestor.com/boards/121874/
-
Godmorgen
-
Her er en opdatering til mit Gubra indlæg om GUBamy. Flere informationer https://proinvestor.com/boards/121874/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind